Dr. Larry K. Wray has over 25 years of experience in the in vitro diagnostics (IVD) industry, having held positions in R&D, project management, manufacturing, and business development.
He has held positions as Senior Director, Development at Celera; R&D Director at Ventana (now part of Roche); and various management positions in R&D, manufacturing, and business development at Abbott Diagnostics. He has been responsible for the development and launch of over 25 products, both immunoassays and molecular diagnostics, on of a variety of instrument platforms, which have included products for blood screening, abused drug screening and therapeutic drug monitoring, bone metabolism, anatomic pathology, retrovirus, and genetic disease, all with both domestic and international registrations. In addition to building and leading product development organizations, he established the core hybridoma facility supporting all product development, the manufacturing organization for the molecular diagnostics business, and led the successful restructuring of the diagnostic division's manufacturing organization, all at Abbott. He authored the strategic plan and established the core reagents program at Ventana, providing the company with an internal capability to develop and manufacture critical product components. He also led the start-up of a new business venture for osteoporosis and diseases of aging at Abbott.
Dr. Wray received his PhD in genetics from the University of Texas at Austin and was an NIH post doctoral fellow in human genetics at the University of Pennsylvania School of Medicine. He is currently consulting with both start-ups and established companies in establishing best-in-class product development capabilities.
